Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
11.15
-0.34 (-2.96%)
At close: Jul 9, 2026, 4:00 PM EDT
10.94
-0.21 (-1.88%)
After-hours: Jul 9, 2026, 6:34 PM EDT
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $489.39 million as of July 9, 2026. Its market cap has decreased by -53.70% in one year.
Market Cap
489.39M
Enterprise Value
477.49M
1-Year Change
-53.70%
Ranking
Category
Stock Price
$11.15
Market Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $489.39M, an increase of 123.00%. That is a compound annual growth rate of 78.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 489.39M | -62.92% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| STAAR Surgical Company | 1.40B |
| BioLife Solutions | 1.33B |
| Azenta | 1.13B |
| Anteris Technologies Global | 945.19M |
| AngioDynamics | 533.95M |
| OraSure Technologies | 292.61M |
| Sanara MedTech | 222.04M |
| Utah Medical Products | 216.70M |